These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7022879)
1. Reversal of acute renal allograft rejection with adjunctive AG therapy. Filo RS; Smith EJ; Leapman SB Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879 [TBL] [Abstract][Full Text] [Related]
2. Therapy of acute cadaveric renal allograft rejection with adjunctive antithymocyte globulin. Filo RS; Smith EJ; Leapman SB Transplantation; 1980 Dec; 30(6):445-9. PubMed ID: 7008293 [TBL] [Abstract][Full Text] [Related]
3. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
4. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related]
6. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin. Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568 [TBL] [Abstract][Full Text] [Related]
7. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations. Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272 [TBL] [Abstract][Full Text] [Related]
8. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab. Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569 [TBL] [Abstract][Full Text] [Related]
9. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients. Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476 [TBL] [Abstract][Full Text] [Related]
10. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731 [TBL] [Abstract][Full Text] [Related]
11. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival]. Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676 [TBL] [Abstract][Full Text] [Related]
13. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction]. Mota A Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737 [TBL] [Abstract][Full Text] [Related]